| Title |
Author |
Type |
Date |
Words |
| Erroneous Activated Coagulation Time During Atrial Flutter Ablation. |
Goldstein, Sheldon; Juarez, Jazmin; Streiff, Agathe |
|
Jan 1, 2020 |
3169 |
| Civica Rx, Hikma to Ship Heparin and Seven Other Essential Injectable Medicines. |
|
|
Dec 11, 2019 |
883 |
| Fibroblast Growth Factor 2 - Pipeline Review, H2 2019. |
|
|
Dec 10, 2019 |
1127 |
| Analysis on the World's Heparin Market, 2019-2024. |
|
|
Nov 22, 2019 |
853 |
| Nawaz's health slips into danger zone. |
|
|
Oct 29, 2019 |
267 |
| Nawaz's health slips into danger zone. |
|
|
Oct 29, 2019 |
269 |
| Nawaz's health slips into danger zone. |
|
|
Oct 28, 2019 |
284 |
| Meitheal Pharmaceuticals Launches Heparin Sodium Injection, USP in the United States. |
|
|
Sep 17, 2019 |
276 |
| Heparin Market Projected to Grow $7.4 Billion by 2026 / Key Players - GlaxoSmithKline plc; Pfizer, Inc.; Baxter; Leo Pharma A/S; Sanofi; and Teva Pharmaceutical Industries Ltd. |
|
|
Sep 11, 2019 |
900 |
| Peptides and Heparin Market to Reap Excessive Revenues by 2026. |
|
|
Sep 5, 2019 |
705 |
| Pig deaths in China reduce supplies of blood thinner. |
|
|
Sep 4, 2019 |
404 |
| Daxor announces 38% rise in BVA-100 cardiology kit sales. |
|
|
Sep 4, 2019 |
153 |
| Unfractionated Heparin Market Size, Share, Trends and Future Growth Predictions and Forecast 2017 --. |
|
|
Aug 1, 2019 |
887 |
| Unfractionated Heparin Market Size, Share, Trends and Future Growth Predictions and Forecast 2017 --. |
|
|
Jul 31, 2019 |
900 |
| Peptides and Heparin Market Foraying into Emerging Economies 2017-2026. |
|
|
Jul 29, 2019 |
755 |
| Anticoagulation Use prior to Common Dental Procedures: A Systematic Review. |
Chahine, Johnny; Khoudary, Marwan N.; Nasr, Samer |
|
Jun 30, 2019 |
7188 |
| COMPARISON OF EMPIRICAL PROTAMINE DOSE STRATEGY WITH CALCULATED DOSE BASED ON HEPARIN DOSE RESPONSE CURVE POST CARDIOPULMONARY BYPASS IN CABG PATIENTS. |
Jehan Essa Abdel Rahman, Fakher-e-Fayaz, Rashad Siddiqi, Rehan Masroor, Rehana Javaid and Syed Muzaf |
|
Jun 30, 2019 |
2638 |
| Unfractionated Heparin Market Size, Share, Trends and Future Growth Predictions till 2025. |
|
|
Jun 14, 2019 |
892 |
| Unfractionated Heparin Market Size, Share, Trends and Future Growth Predictions till 2025. |
|
|
Jun 13, 2019 |
905 |
| Peptides and Heparin Market Set to Deliver Major Revenue Shares during the Forecast Period. |
|
|
Jun 7, 2019 |
783 |
| Heparin Market Analysis and Evolving Opportunities Studied for the Period Until 2025. |
|
|
May 2, 2019 |
713 |
| Heparin Market Analysis and Evolving Opportunities Studied for the Period Until 2025. |
|
|
May 1, 2019 |
987 |
| Schreiner MediPharm collaborates with B. Braun Medical. |
|
|
May 1, 2019 |
317 |
| Peptide and Heparin Market: Vendors of Peptide Therapeutics are Outsourcing Manufacturing Processes. |
|
|
Apr 19, 2019 |
963 |
| Peptides and Heparin Market Development and Trends Report through 2017-2026. |
|
Report |
Mar 18, 2019 |
748 |
| Heparin Market Offering Trends, Share, Size, Growth until the End of 2025. |
|
|
Mar 6, 2019 |
712 |
| Heparin Market Offering Trends, Share, Size, Growth until the End of 2025. |
|
|
Mar 6, 2019 |
992 |
| Molecular characteristics of polysulfated fractions from the green seaweed Caulerpa cupressoides and actions on thrombin generation in vitro. |
Rodrigues, Jose Arievilo Gurgel; Benevides, Norma Maria Barros; Tovar, Ana Maria Freire; de Souza Mo |
|
Jan 1, 2019 |
9124 |
| The Hemostatic Effect of Ankaferd Blood Stopper in Rat Bleeding Models with Antithrombotic Drug Therapy: An Experimental In Vivo Study/Antitrombotik ilac Tedavisi Uygulanan Sican Kanama Modellerinde Ankaferd Kanama Durdurucusunun Hemostatik Etkisi: In Vivo Deneysel Bir Calisma. |
Akbulut, Nihat; Akar, Ilker; Eren, Hakan; Asian, Cemal; Tumer, Mehmet Kemal |
Report |
Dec 1, 2018 |
3546 |
| Peptides and Heparin Market Expected to Grow at a CAGR of 8.10% by 2026. |
|
|
Nov 14, 2018 |
650 |
| Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention. |
Li, Zhi-Zhong; Tao, Ying; Wang, Su; Yin, Cheng-Qian; Gao, Yu-Long; Cheng, Yu-Tong; Li, Zhao; Ma, Cha |
Report |
Oct 20, 2018 |
4475 |
| Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers. |
Beck, Hans C.; Jensen, Lisette O.; Gils, Charlotte; Hondo, Albertine M.M.; Frydland, Martin; Hassage |
|
Oct 1, 2018 |
7331 |
| 6 Key Projections on Future of Peptide and Heparin Market for Forecast Period 2017 -- 2026. |
|
|
Sep 26, 2018 |
764 |
| 6 Key Projections on Future of Peptide and Heparin Market for Forecast Period 2017 -- 2026. |
|
|
Sep 26, 2018 |
764 |
| Fresenius Kabi introduces Heparin Sodium in freeflex containers-BYLN-. |
|
|
Aug 6, 2018 |
457 |
| Fresenius Kabi introduces Heparin Sodium in freeflex containers -BYLN- Business Wire. |
|
|
Aug 6, 2018 |
218 |
| Low-Molecular Weight Heparin and Complications of Subcutaneous Injection: How Important Is Injection Site Selection? |
Babaieasl, Faezeh; Yarandi, Hossein; Moosazadeh, Mahmood; Kheradmand, Motahareh |
Report |
May 1, 2018 |
3212 |
| Endogenous Heparin Interferes with Quantification of MicroRNAs by RT-qPCR. |
Boileau, Adeline; Cardenas, Christian L. Lino; Lindsay, Mark E.; Devaux, Yvan |
Letter to the editor |
May 1, 2018 |
1267 |
| RIGHT RENAL VEIN THROMBOSIS WITH POST REVERSIBLE ENCEPHALOPATHY SYNDROME WITH RIGHT ATROPHIC KIDNEY IN A NEONATE. |
Verma, Shubhi; Mehrotra, Gunjan Kela; Parihar, Rashmi; Arora, Keval Kishore |
Case study |
Apr 30, 2018 |
1316 |
| Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention. |
Huang, Ji; Li, Nan; Li, Zhao; Hou, Xue-Jian; Li, Zhi-Zhong |
Report |
Apr 15, 2018 |
4296 |
| The effect of different forms of heparin on point-of-care blood gas analysis. |
Sandler, P.; Goldstein, L.N. |
|
Mar 1, 2018 |
5232 |
| Congress Asks FDA to Investigate Heparin Supply. |
|
|
Feb 8, 2018 |
128 |
| Male Pronuclear Formation and Embryo Development Following Intracytoplasmic Injection of Ovine Pretreated Sperm. |
Shirazi, Abolfazl; Golestanfar, Arefeh; Bashiri, Masomeh; Ahmadi, Ebrahim; Shams-Esfandabadi, Naser |
Report |
Jan 1, 2018 |
5513 |
| Paciente con trombocitopenia trombotica inducida por heparina en hemodialisis: abordaje de la anticoagulacion del circuito/Thrombotic patient with heparin-induced thrombocytopenia in hemodialysis: addressing circuit anticoagulation. |
Martinez, Mirian Garcia; Garcia, Miguel Merino; Perez, Alicia Labrador |
|
Jan 1, 2018 |
2830 |
| Lethal End of Spectrum of Clots-Thrombotic Storm. |
Rana, Muhammad Asim; Mady, Ahmed F.; Lashari, Abdullah Ali; Eltreafi, Rehab; Fischer-Orr, Nicola; Na |
|
Jan 1, 2018 |
3231 |
| Treatment of Bleeding Diathesis Associated with a Heparin-Like Anticoagulant in Plasma Cell Neoplasia Using Protamine. |
Willner, Christopher A.; Chisti, Mohammed M. |
|
Jan 1, 2018 |
1835 |
| Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis. |
Sunseri, Maria; Ahuja, Tania; Wilcox, Tanya; Green, David |
|
Jan 1, 2018 |
2751 |
| Effects of Transplanted Heparin-Poloxamer Hydrogel Combining Dental Pulp Stem Cells and bFGF on Spinal Cord Injury Repair. |
Luo, Lihua; Albashari, Abdullkhaleg Ali; Wang, Xiaoyan; Jin, Ling; Zhang, Yanni; Zheng, Lina; Xia, J |
|
Jan 1, 2018 |
8453 |
| Heparin-Based Nanoparticles: An Overview of Their Applications. |
Rodriguez-Torres, Maria del Pilar; Acosta-Torres, Laura Susana; Diaz-Torres, Luis Armando |
|
Jan 1, 2018 |
6683 |
| Significance of Heparin-Binding Protein and D-dimers in the Early Diagnosis of Spontaneous Bacterial Peritonitis. |
Mikula, Tomasz; Sapula, Mariusz; Jablonska, Joanna; Kozlowska, Joanna; Stanczak, Wojciech; Krankowsk |
|
Jan 1, 2018 |
3838 |
| Mylan NV wins US FDA approval for Heparin Sodium Injection as an anticoagulant in blood transfusions. |
|
|
Dec 4, 2017 |
201 |
| Mylan NV wins US FDA approval for Heparin Sodium Injection as an anticoagulant in blood transfusions. |
|
|
Dec 4, 2017 |
197 |
| Anaphylaxis after Administration of Heparin Flush. |
Ruggiero, Gabrielle; Holle, Lisa M.; Baccaro, Nancy; Oliver, Ellen |
|
Nov 1, 2017 |
2474 |
| Patient Blood Management for Cardiac Surgery. |
|
Report |
Sep 22, 2017 |
578 |
| Which lab test is best to monitor heparin therapy? What the evidence says. CNE SERIES. (Nursing Pharmacology). |
Heil, Joyce; Blazeck, Alice; Haines, Jane |
Report |
May 1, 2017 |
3030 |
| Which lab test is best to monitor heparin therapy? What the evidence says. |
Heil, Joyce; Blazeck, Alice; Haines, Jane |
|
May 1, 2017 |
3030 |
| En el sellado del cateter venoso central en hemodialisis, ?presenta el uso de citrato respecto al uso de heparina menos complicaciones de infeccion? Una revision de la literatura. |
Nadal Servera, Mateu; Sanchez Marimon, Ester |
|
Apr 1, 2017 |
4233 |
| Evaluation of a single dimension gel electrophoresis with immunofixation, with and without heparin, for heparin binding site defect in antithrombin deficiency. |
Legner, Janko; Phillips, Julia K.; Kendrick, Christopher J. |
Report |
Apr 1, 2017 |
2694 |
| Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury. |
Xie, Nianlin; Huan, Menglei; Tian, Feng; Gu, Zhongping; Li, Xiaofei |
Report |
Jan 1, 2017 |
3421 |
| Redox and pH Responsive Poly (Amidoamine) Dendrimer-Heparin Conjugates via Disulfide Linkages for Letrozole Delivery. |
Nguyen, Thanh Luan; Nguyen, Thi Hiep; Nguyen, Cuu Khoa; Nguyen, Dai Hai |
Report |
Jan 1, 2017 |
4345 |
| Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera. |
Meyer, Sara C.; Steinmann, Eva; Lehmann, Thomas; Muesser, Patricia; Passweg, Jakob R.; Skoda, Radek |
Report |
Jan 1, 2017 |
9818 |
| Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism. |
Adediran, Samuel; Agostino, Nicole |
Clinical report |
Jan 1, 2017 |
3058 |
| Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty. |
Baker, Kevin; Lim, Ming Y. |
Clinical report |
Jan 1, 2017 |
2431 |
| Extensive Intracardiac and Deep Venous Thromboses in a Young Woman with Heparin-Induced Thrombocytopenia and May-Thurner Syndrome. |
Kim, Yekaterina; Choi, Daniel C.; Zaidi, Ali N. |
Clinical report |
Jan 1, 2017 |
1674 |
| Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke? |
Kulairi, Zain; Deol, Nisha; Tolly, Renee; Manocha, Rohan; Naseer, Maliha |
Clinical report |
Jan 1, 2017 |
1501 |
| Comparison of outcomes: nurse-driven vs. physician-driven weight-based intravenous heparin protocol. |
Davis, Kelly W.; McMillan, Margorie A.; Perkins, Jennifer; Beavan, Heidi R.; Corum, Melissa; Miller, |
Report |
Nov 1, 2016 |
4362 |
| Heparin Anticoagulant Market USD 10.8 Billion by 2020, Published by iHealthcareAnalyst, Inc.. |
|
|
Oct 27, 2016 |
485 |
| Haemodialysis in patients at high risk of bleeding. |
Stephenson, Matthew D.; Sinclair, Peter M. |
Report |
Jul 1, 2016 |
7222 |
| Antithrombotic and antiinflammatory effect of heparin conjugated poly(l-lactide) on inflammation induced cyclooxygenase. |
Mandal, Ramila D.; Patel, Payal J.; Patel, Nisha R.; Patel, Himanshu J.; Kale, Sunil P.; Engineer, C |
Report |
Apr 1, 2016 |
3488 |
| Cerebral Hemorrhage Complicating Heparin-induced Thrombocytopenia after Percutaneous Coronary Intervention: A Clinical Dilemma of Medical Treatment. |
Qin, Xue; Zhang, Bo |
Clinical report |
Nov 1, 2015 |
842 |
| Comparative evaluation of LMW heparinized infusion versus Basalsalt Solution (BSS) in conjenital, complicated and traumatic cataract surgery. |
Singh, Harpal; Saini, V.K. |
Clinical report |
Mar 30, 2015 |
1249 |
| The Influence of Free Hemoglobin and Bilirubin on Heparin Monitoring by Activated Partial Thromboplastin Time and Anti-Xa Assay. |
Kostousov, Vadim; Nguyen, Kim; Hundalani, Shilpa G.; Teruya, Jun |
|
Nov 1, 2014 |
2651 |
| A simple functional assay for heparin-induced thrombocytopenia/thrombosis syndrome using a full blood count analyser. |
Chan, George T.C.; Lee, Sophie H.S.; Jones, Simon D.F. |
Report |
Aug 1, 2014 |
1911 |
| Imaging findings on heparin-induced thrombocytopenia with thrombosis. |
Rohena-Quinquilla, Ivan R.; Baird, Dean |
Case study |
Apr 1, 2014 |
1427 |
| Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomised trial. |
Babu, B.V. Mahesh; Rao, A.S. Kameswara; Rajesh, K.; Babu, V. Harinath |
Report |
Jan 6, 2014 |
1763 |
| Peritoneal reactivity evaluation in horses subjected to experimental small colon enterotomy and treated with subcutaneous heparin. |
Alonso, Juliana de Moura; Rodrigues, Karoline Alves; Yamada, Ana Lucia Miluzzi; Watanabe, Marcos Jun |
Report |
Jan 1, 2014 |
4511 |
| Molecular weight determination of LMWH SEC/MALS vs. SEC/UV-RI. |
|
|
Dec 1, 2013 |
331 |
| Effect of heparin administration during coronary angiography on vascular or peripheral complications: a single-blind randomized controlled clinical trial. |
Gharakhani, Mohsen; Emami, Farzad |
Report |
Dec 1, 2013 |
3217 |
| Collagen dressing versus heparin dressing in burn wound management. |
Rai, Rakesh; Sudarshan, Sunil H.; Dsouza, Reshmina; Saldhana, Elroy; Aithala, P.S. |
Clinical report |
Nov 25, 2013 |
2276 |
| Heparin-induced thrombocytopenia. |
Frazer, Cynthia A. |
Clinical report |
Nov 1, 2013 |
973 |
| Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive. |
Tientadakul, Panutsaya; Kongkan, Chulalak; Chinswangwatanakul, Wimol |
Report |
Nov 1, 2013 |
5055 |
| Heparin label alert and CDC health advisory related to synthetic opioid overdose. |
|
|
Oct 1, 2013 |
520 |
| Heparin overdose for preemie. |
|
|
Sep 1, 2013 |
231 |
| National Alert! Important changes in heparin vial labeling. |
|
|
Aug 1, 2013 |
198 |
| Heparin selectively affects the quantification of microRNAs in human blood samples. |
Boeckel, Jes-Niels; Thome, Claudia E.; Leistner, David; Zeiher, Andreas M.; Fichtlscherer, Stephan; |
Letter to the editor |
Jul 1, 2013 |
1156 |
| China's heparin revisited: what went wrong and has anything changed? |
Mintz, Clifford; Liu, John |
|
Jan 1, 2013 |
3982 |
| The optimum number and types of plasma samples necessary for an accurate activated partial thromboplastin time-based heparin therapeutic range. |
Marlar, Richard A.; Gausman, Jana |
Report |
Jan 1, 2013 |
4118 |
| Hats off to HIT: a case report. |
Ahmad, Akhwand Shakeel; Al-Layla, Dhia Jaber; Dhinakar, Manjula |
Case study |
May 1, 2012 |
3089 |
| Anticoagulant activity of sulfated polysaccharides fractions from an aqueous extract obtained from the red seaweed Halymenia floresia (Clemente) C. Agardh/Atividade anticoagulante de fracoes polissacaridicas sulfatadas de um extrato aquoso obtido da alga marinha vermelha Halymenia floresia (Clemente) C. Agardh. |
Rodrigues, Jose Arievilo Gurgel; de Queiroz, Ismael Nilo Lino; Bessa, Erika Facanha; Coura, Chistian |
|
Oct 1, 2011 |
5081 |
| Anticoagulation for DVT in calf may reduce clot propagation risk. |
|
Brief article |
Aug 31, 2011 |
130 |
| Patient outcomes, economic benefits associated with a heparin change in hemodialysis, and nurses' satisfaction. |
Chevalier, Bernadette A.M.; Thompson, Kara; Hudson, Skawna; Constantine, Charles |
Report |
Jul 1, 2011 |
6130 |
| Heparin plays key role in allergic, inflammatory reactions. |
|
|
Feb 27, 2011 |
233 |
| Stop that clot: haemostasis and anticoagulation: this is the first in a series of clinical articles Kai Tiaki Nursing New Zealand is publishing to provide a convenient way for nurses to earn continuing professional development hours. |
Casey, Georgina |
Report |
Feb 1, 2011 |
4569 |
| The effect of heparin on the cell cycle in human B-iymphoblasts: an in vitro study / Heparinin insan B-lenfositlerinin hucre dongusune etkisi: bir in vitro calisma. |
Aksoy, Ayse; Erduran, Erol; Tekelioglu, Yavuz; Mutlu, Mehmet; Gedik, Yusuf |
|
Dec 1, 2010 |
5859 |
| Food and Drug Administration: Response to Heparin Contamination Helped Protect Public Health; Controls That Were Needed for Working With External Entities Were Recently Added. |
|
|
Dec 1, 2010 |
647 |
| Raising awareness of heparin-induced thrombocytopenia in subarachnoid hemorrhage. |
Robinson, Jennifer D. |
Clinical report |
Aug 1, 2010 |
2180 |
| Safety of percutaneous dilational tracheostomy in coagulopathic patients. |
Pandian, Vinciya; Vaswani, Ravi S.; Mirski, Marek A.; Haut, Elliott; Gupta, Shivam; Bhatti, Nasir I. |
|
Aug 1, 2010 |
3436 |
| APP Pharmaceuticals Inc secures marketing clearance for preservative-free Heparin Lock Flush Solution, USP. |
|
|
Jul 6, 2010 |
163 |
| Validation of a dosing regimen for fixed-dose, weight-adjusted, subcutaneous unfractionated heparin for the acute treatment of venous thrombo-embolism in a population from a resource-constrained environment. |
Munsamy, J.I.; Kertland, H.; Parrish, A. |
Report |
Jul 1, 2010 |
1357 |
| Heparin and [Na.sub.2]EDTA as anticoagulants for hybrid surubim catfish (Pseudoplatystoma reticulatum x P. corruscans): efficacy and hematological changes/Heparina e [Na.sub.2]EDTA como anticoagulantes para surubim hibrido (Pseudoplatystoma reticulatum x P. corruscans): eficacia e alteracoes hematologicas. |
Ishikawa, Marcia Mayumi; de Padua, Santiago Benites; Satake, Fabiana; Hisano, Hamilton; Jeronimo, Ga |
|
Jul 1, 2010 |
3323 |
| Relationship of hemoglobin concentration to packed cell volume in avian blood samples. |
|
Report |
Jun 1, 2010 |
3654 |
| Endogenous heparin levels in the controlled asthmatic patient. |
Davids, Hajierah; Ahmed, Ayesha; Oberholster, Ari; van der Westhuizen, Christo; Mer, Mervyn; Havlik, |
|
May 1, 2010 |
1153 |
| Starting heparin in the emergency department (ED) rather than after admission may improve the survival of patients with acute pulmonary embolism (PE), according to a Mayo Clinic study. |
|
Clinical report |
Feb 1, 2010 |
311 |
| The monitoring of heparin induced thrombocytopenia following surgery: an audit and international survey. |
Rogers, Benedict A.; Cowie, Andrew S. |
Report |
Feb 1, 2010 |
1703 |
| Hospital-acquired malaria associated with dispensing diluted heparin solution. |
Al-Hamdan, Nasser A. |
Report |
Dec 1, 2009 |
873 |
| Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients/Medikal hastalarda anti-heparin trombosit faktor 4 antikor ve heparine bagli trombositopeni sikligi. |
Demir, Muzaffer; Tekgunduz, Emre; Edis, Mustafa; Duran, Enver; Kurum, Turan; Yigitbasi, Omer; Yuksel |
Clinical report |
Dec 1, 2009 |
2615 |
| Heparin potency will change. |
|
Brief article |
Nov 1, 2009 |
174 |
| Revised standards issued for heparin. |
|
Law overview |
Oct 26, 2009 |
554 |
| Hospira broadens its heparin product portfolio. |
|
Brief article |
Sep 28, 2009 |
183 |
| Dialysis at Guys in the 1970s. |
Silvester, Valerie |
Personal account |
Jul 1, 2009 |
1576 |
| Is heparin required to prevent thrombosis of an indwelling catheter? |
Hellebrand, Alice |
|
May 1, 2009 |
1668 |
| Standards for two drugs revised. |
|
Brief article |
Mar 16, 2009 |
185 |
| Lawmaker asks for heparin review. |
Anderson, Jane |
Brief article |
Jan 1, 2009 |
183 |
| Lawmaker asks for heparin review. |
Anderson, Jane |
Brief article |
Jan 1, 2009 |
183 |
| Resources aid attorneys representing clients harmed by heparin. |
|
|
Nov 1, 2008 |
401 |
| The use of alternative anti-coagulation strategies for a nocturnal home hemodialysis patient with heparin-induced thrombocytopenia. |
Faratro, Rose; D'Gama, Celine; Chan, Christopher |
Clinical report |
Oct 1, 2008 |
3377 |
| Safer blood thinner. |
Castelvecchi, Davide |
Brief article |
Sep 13, 2008 |
82 |
| Some cancers need prolonged, high-dose VTE prophylaxis. |
Zoler, Mitchel L. |
|
Jul 15, 2008 |
538 |
| ConsumerLab points out irony of heparin contamination with chondroitin; calls for better testing. |
Obermeyer, William |
Brief article |
Jul 1, 2008 |
276 |
| Heparin contamination. |
Klotter, Jule |
|
Jul 1, 2008 |
465 |
| Heparin FDA recall for all provider types. |
|
|
Jun 1, 2008 |
86 |
| U.S., China clash over heparin case. |
|
Brief article |
May 19, 2008 |
110 |
| Tracking Washington. |
|
Brief article |
May 5, 2008 |
239 |
| Baxter CEO says heparin contamination appears deliberate. |
|
Brief article |
May 5, 2008 |
201 |
| Heparin contaminant's tie to adverse events clear. |
Mechcatie, Elizabeth |
|
May 1, 2008 |
608 |
| US regulators suspect that Baxter International Inc's (Deerfield IL) blood-thinner heparin, linked to deaths and allergic reactions, was intentionally contaminated to boost profits. |
|
Brief article |
Apr 21, 2008 |
197 |
| Sixty-two people given the blood-thinner heparin died since January 2007 after suffering allergic reactions or low blood pressure, up from 19 previously reported, US regulators said. |
|
Brief article |
Apr 14, 2008 |
165 |
| Baxter's heparin contaminant identified. |
|
Brief article |
Mar 24, 2008 |
227 |
| Preventing substitution errors involving high-concentration heparin products. |
Koczmara, Christine; Cheng, Roger; Hyland, Sylvia |
|
Mar 22, 2008 |
2418 |
| Tests of Baxter heparin reveal contamination. |
Mechcatie, Elizabeth |
|
Mar 15, 2008 |
547 |
| Index guides discharge after pulmonary embolism. |
Wendling, Patrice |
|
Mar 1, 2008 |
694 |
| Inpatient VTE prophylaxis subpar worldwide. |
Walsh, Nancy |
Report |
Mar 1, 2008 |
451 |
| Practice resource network. |
Leeper, A. Barbara |
|
Jan 1, 2008 |
1267 |
| Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy. |
Schapkaitz, E.; Jacobson, B.F. |
Clinical report |
Dec 1, 2007 |
1794 |
| What are the best agents for preventing VTE in hospital patients? |
|
Clinical report |
Oct 1, 2007 |
454 |
| The use of heparin in preparing samples for blood-gas analysis. |
Higgins, Chris |
|
Oct 1, 2007 |
5139 |
| Heparin cuts VTE risk, but not mortality. |
|
|
Sep 15, 2007 |
128 |
| Systemic anticoagulant effect of low-dose subcutaneous unfractionated heparin as determined using thrombelastography. |
Matzelle, S.J.; Gibbs, N.M.; Weightman, W.; Sheminant, M.; Rowe, R.; Baker, S. |
Clinical report |
Aug 1, 2007 |
3587 |
| Heparin is a widely used drug--just about any health worker will deal with patients on the drug. |
Opie, Jessica |
Clinical report |
Jun 1, 2007 |
2453 |
| Low-weight heparin slashes poststroke VTE risk. |
MacNeil, Jane Salodof |
|
Mar 1, 2007 |
577 |
| Subcutaneous unfractionated heparin: ready for prime time? |
Ebbert, Jon O.; Tangalos, Eric G. |
|
Nov 15, 2006 |
832 |
| Outpatient unfractionated heparin safe. |
|
Brief article |
Sep 15, 2006 |
255 |
| Old drug can stop clots as well as newer drug does. |
|
Brief article |
Sep 9, 2006 |
286 |
| Heparin catheter flush finds a home at CDRH. |
|
|
Sep 1, 2006 |
101 |
| Watch for heparin-induced thrombocytopenia. |
Jancin, Bruce |
Clinical report |
Aug 15, 2006 |
565 |
| Answering your questions; Heparin drawing tubes. |
Baer, Daniel M. |
Column |
Aug 1, 2006 |
619 |
| Heparin fails to cut rate of DVT/PE after prostatectomy. |
|
|
Aug 1, 2006 |
481 |
| Who is responsible? |
Bayley, Carol; Berlinger, Nancy |
|
May 1, 2006 |
1650 |
| FDA alert on NaCl, heparin preloaded IV Flush syringes. |
Wachter, Kerri |
Brief Article |
May 1, 2005 |
95 |
| Aspirin, heparin show preeclampsia benefits: outcomes improved in those with preeclampsia and a low-birth-weight infant in a previous pregnancy. |
Tucker, Miriam E. |
|
Feb 1, 2005 |
596 |
| Low-molecular-weight heparin helps in acute MI. |
Zoler, Mitchel L. |
|
Jan 1, 2005 |
774 |
| Enoxaparin matches heparin's efficacy in ACS. |
Zoler Mitchel L. |
|
Jun 1, 2004 |
1024 |
| Synthetic agent may stave off postsurgical DVT: compared with heparins. |
Kirn, Timothy F. |
|
Mar 15, 2004 |
479 |
| Oral heparin takes a step forward, despite problems. (Liquid Form Limited by Bad Taste). |
Zoler, Mitchel L. |
|
Mar 1, 2003 |
469 |
| Readers are asked to respond on heparin prescription and administration. (Clinical Consult). |
Dinwiddie, Lesley C. |
|
Feb 1, 2003 |
771 |
| Postphlebitic Ulcer risk higher with Warfarin. (Compared to LMWH). |
DeMott, Kathryn |
|
Mar 1, 2002 |
253 |
| Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein a: use in first-trimester screening for down syndrome. |
Qin, Qiu-Ping; Christiansen, Michael; Pettersson, Kim |
|
Mar 1, 2002 |
7598 |
| Drug Update: Outpatient Treatment of Deep Vein Thrombosis. |
Zoler, Mitchel L.; Imperio, Winnie Anne |
|
Dec 1, 2001 |
853 |
| Drug update: Outpatient treatment of deep vein thrombosis. |
Zoler, Mitchel L.; Imperio, Winnie Anne |
Brief Article |
Dec 1, 2001 |
829 |
| Hemocompatible coatings for medical devices. (SurModics, Inc.: solutions in medical manufacturing). |
|
Brief Article |
Nov 1, 2001 |
102 |
| Different heparin lots: does it matter? |
Smythe, Maureen A.; Koerber, John M.; Westley, Susan J.; Balasubramaniam, Mamtha; Mattson, Joan C. |
|
Nov 1, 2001 |
2108 |
| Venous Thromboembolism. |
Fowler, Susan B. |
Brief Article |
Aug 1, 2001 |
163 |
| Temporal Aspects of Heparin-Induced Thrombocytopenia. |
|
Brief Article |
Jun 1, 2001 |
230 |
| Heparin-Induced Disorder. |
|
Brief Article |
Jun 1, 2001 |
189 |
| Is once- or twice-a-day enoxaparin as effective as unfractionated heparin for the treatment of venous thromboembolism (VTE)? |
Marshland, Thomas; Newton, Warren |
|
May 1, 2001 |
794 |
| Evaluation of the TAS analyzer and the Low-Range Heparin Management Test in patients undergoing extracorporeal membrane oxygenation. |
Ambrose, Theresa M.; Parvin, Curtis A.; Mendeloff, Eric; Luchtman-Jones, Lori |
Clinical report |
May 1, 2001 |
4613 |
| Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact. |
De Smet, Rita; van Kaer, Jacqueline; Liebich, Hartmut; Lesaffer, Gerrit; Verstraete, Alain; Dhondt, |
|
May 1, 2001 |
6978 |
| Prudent heparin use or abuse. |
Elpers, Louise |
|
Feb 1, 2001 |
681 |
| More on troponin assays and heparin. |
Buechler, Kenneth F.; Nakamura, Kevin K.; Gerhardt, Willie; Nordin, Gunnar; Isaksson, Anders; Haglun |
Letter to the editor |
Jan 1, 2001 |
2960 |
| Pathophysiology of Heparin-Induced Thrombocytopenia. |
Fabris, Fabrizio; Ahmad, Sarfraz; Cella, Giuseppe; Jeske, Walter P.; Walenga, Jeanine M.; Fareed, Ja |
|
Nov 1, 2000 |
8656 |
| GP IIb/IIIa Inhibitors Safe With Enoxaparin. |
JANCIN, BRUCE |
|
Oct 15, 2000 |
503 |
| Drug Update: Anticoagulant Therapy for Unstable Angina. |
Jancin, Bruce |
Brief Article |
Aug 1, 2000 |
742 |
| LMW Heparin Edges Out Unfractionated. |
Zoler, Mitchel L. |
Brief Article |
Apr 15, 2000 |
256 |
| Heparin-Induced Thrombocytopenia in Hemodialysis Patients. |
Brouwer, Deborah J.; Peterson, Patt |
|
Apr 1, 2000 |
1449 |
| Enoxaparin Beats Heparin in Inpatients for VTE Prophylaxis. |
CHENG, GUANG-SHING |
|
Feb 15, 2000 |
841 |
| Inhaled Enoxaparin Decreases Bronchoconstriction in Asthmatics. |
Cheng, Guang-Shing |
Brief Article |
Jan 1, 2000 |
195 |
| Heparin-Induced Thrombocytopenia (HIT). |
Conley, Kim; Letizia, Marijo |
|
Dec 1, 1999 |
1816 |
| Trial Questions Primacy of Fibrinolysis in MI. |
JANCIN, BRUCE |
|
Oct 15, 1999 |
708 |
| LMWH Doesn't Cut Recurrent Stroke Risk in Atrial Fibrillation. |
IMPERIO, WINNIE ANNE |
|
Oct 15, 1999 |
296 |
| LOW-MOLECULAR-WEIGHT HEPARIN FOR DEEP VENOUS THROMBOSIS. |
Bielanski, Thomas E. |
|
Sep 1, 1999 |
796 |
| LMW Heparins Pose Problem in Ob. Anesthesia. |
JANCIN, BRUCE |
|
Aug 15, 1999 |
724 |
| Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis? |
Brewer, Dan |
|
Sep 1, 1998 |
6041 |
| Low molecular weight heparins: how they work ... what they do. |
Hillis, Laurie Berg |
|
Jun 1, 1998 |
2232 |
| A new form of heparin is changing treatment of thrombotic disorders. |
Capriotti, Theresa |
|
Apr 1, 1998 |
3511 |
| Patency of 24-gauge peripheral intermittent infusion devices: a comparison of heparin and saline flush solutions. |
Mudge, Bridget; Forcier, Dion; Slattery, Mary Jo |
|
Mar 1, 1998 |
3408 |
| Plasma lipoprotein profiles change significantly during cardiac catheterization. |
Miida, Takashi; Otsuka, Hideaki; Tsuchiya, Atsushi; Okada, Masahiko |
|
Mar 1, 1998 |
3127 |
| Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration. |
Ramamurthy, Narayanan; Baliga, Narayan; Wahr, Joyce A.; Schaller, Ulrich; Yang, Victor C.; Meyerhoff |
|
Mar 1, 1998 |
4745 |
| The use of heparin and normal saline flushes in neonatal intravenous catheters. |
Paisley, Marilyn Krueger; Stamper, Maura; Brown, Julie; Brown, Nancy; Ganong, Larry H. |
|
Sep 1, 1997 |
4006 |
| Heparin interference with sodium and albumin assays. |
Karon, Brad S.; Kempe, Kirsten C.; Scott, Mitchell G. |
Letter to the editor |
Apr 1, 1997 |
888 |
| Effects of varying intervals between heparin flushes on pediatric center longevity. |
Crews, Barbara E.; Gnann, Kathy K.; Rice, Marti H.; Kee, Carolyn C. |
|
Jan 1, 1997 |
4668 |
| A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. |
Dumas, R.; Woitinas, F.; Kutnowski, M.; Nickolic, I.; Berberich, R.; Abedinpour, F.; Zoeckler, S.; G |
|
Nov 1, 1994 |
3162 |
| Shooting down those postop clots. |
|
|
May 14, 1988 |
238 |
